/IQVIA%20Holdings%20Inc%20logo%20on%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Durham, North Carolina-based IQVIA Holdings Inc. (IQV) provides healthcare research services. Valued at $35.8 billion by market cap, the company offers analytics, technology solutions, and clinical research services to the life sciences industry which helps them in the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients. The contract research giant is expected to announce its fiscal fourth-quarter earnings for 2024 on Wednesday, Feb. 12.
Ahead of the event, analysts expect IQV to report a profit of $2.87 per share on a diluted basis, up 8.3% from $2.65 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.